BCIQ Profiles

Company Profile Report
DIST_0210_s41467-021-21159-7

Zelboraf-based PROTAC for melanoma, lung cancer expressing BRAF mutations

Feb 26, 2021 | 10:04 PM GMT

DISEASE CATEGORY: Cancer

INDICATION: Melanoma; lung cancer

A Yale University and Memorial

Read the full 236 word article

How to gain access

Continue reading with a
two-week free trial.